A Real World Data of Ocrelizumab in Multiple Sclerosis

被引：0
作者：
Beckmann, Y.
Uzunkopru, C.
机构：
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1240
引用
收藏
页码：671 / 671
页数：1
相关论文
共 50 条
[21]   Safety and effectiveness of ocrelizumab in multiple sclerosis: a real-world study from spain [J].
Sempere, A. ;
Berenguer-Ruiz, L. ;
Burgos-San Jose, A. ;
Aragones, M. ;
Navarro-Lopez, M. D. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :553-553
[22]   Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenario [J].
Lorefice, Lorena ;
Mellino, Paolo ;
Frau, Jessica ;
Coghe, Giancarlo ;
Fenu, Giuseppe ;
Cocco, Eleonora .
NEUROLOGICAL SCIENCES, 2024, 45 (08) :3951-3959
[23]   Real-world comparison of Rituximab and Ocrelizumab effectiveness in Multiple Sclerosis: a multicenter study [J].
Smolik, Krzysztof ;
Camilli, Federico ;
Del Prete, Claudia ;
Foschi, Matteo ;
Surcinelli, Andrea ;
Curti, Erica ;
Tsantes, Elena ;
Ferri, Caterina ;
Guareschi, Angelica ;
Bazzurri, Veronica ;
Montepietra, Sara ;
Simone, Anna Maria ;
Mancinelli, Luca ;
Lugaresi, Alessandra ;
Falzone, Francesca ;
Piscaglia, Maria Grazia ;
Granella, Franco ;
Baldi, Eleonora ;
Pesci, Ilaria ;
Immovilli, Paolo ;
Santangelo, Mario ;
Cardi, Martina ;
Fiore, Alessia ;
De Napoli, Giulia ;
Vitetta, Francesca ;
Ferraro, Diana .
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) :373-374
[24]   Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis [J].
Davies, Laura ;
Shehadeh, Rasheed ;
Watkins, W. John ;
Jolles, Stephen ;
Robertson, Neil P. ;
Tallantyre, Emma C. .
JOURNAL OF NEUROLOGY, 2025, 272 (06)
[25]   Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study [J].
Skoric, Magdalena Krbot ;
Kes, Vanja Basic ;
Grbic, Nevena ;
Lazibat, Ines ;
Pavelin, Sanda ;
Zubonja, Tea Mirosevic ;
Komso, Milica ;
Piskac, Spomenka Kidemet ;
Abicic, Ana ;
Piskac, Dominik ;
Adamec, Ivan ;
Barun, Barbara ;
Gabelic, Tereza ;
Habek, Mario .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 89
[26]   Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study [J].
Lanzillo, Roberta ;
Carotenuto, Antonio ;
Signoriello, Elisabetta ;
Iodice, Rosa ;
Miele, Giuseppina ;
Bisecco, Alvino ;
Maniscalco, Giorgia Teresa ;
Sinisi, Leonardo ;
Romano, Felice ;
Di Gregorio, Maria ;
Lavorgna, Luigi ;
Trojsi, Francesca ;
Moccia, Marcello ;
Fratta, Mario ;
Capasso, Nicola ;
Dubbioso, Raffaele ;
Petracca, Maria ;
Spiezia, Antonio Luca ;
Gallo, Antonio ;
Petruzzo, Martina ;
De Angelis, Marcello ;
Bonavita, Simona ;
Lus, Giacomo ;
Tedeschi, Gioacchino ;
Morra, Vincenzo Brescia .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
[27]   A real-world data study of coronavirus-2019 disease severity in patients with multiple sclerosis treated with ocrelizumab [J].
Dillon, P. ;
Waqar, A. ;
Roumpanis, S. ;
Martinec, M. ;
Muros-Le Rouzic, E. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :103-104
[28]   Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers [J].
Diem, L. ;
Ovchinnikov, A. ;
Friedli, C. ;
Hammer, H. ;
Kamber, N. ;
Chan, A. ;
Salmen, A. ;
Findling, O. ;
Hoepner, R. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 86
[29]   Two-year real-world experience with ocrelizumab in the treatment of patients with multiple sclerosis [J].
Vollmer, B. ;
Ijadi, N. ;
Declusin, A. ;
Nair, K. ;
Sillau, S. ;
Corboy, J. ;
Vollmer, T. ;
Alvarez, E. .
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) :595-596
[30]   Real-world experience of ocrelizumab in patients with multiple sclerosis: A single-center study [J].
Rabia, Koc Emine ;
Faruk, Turan Omer ;
Furkan, Saridas ;
Dursun, Ceylan ;
Guven, Ozkaya .
NEUROLOGY ASIA, 2025, 30 (01) :251-259
12345